Although the number of B16-F10 cells increased by approximately 25% for a wild-type endothelial barrier, no increase in B16-F10 tumor cells was seen for a Ripk3−/− endothelial barrier (Figure 5d). The gene discussed is RIPK3; the disease is neoplasm.